Sandoz launches generic antibiotic Daptomycin in US, strategically growing injectables portfolio and strengthening hospital offering
- Daptomycin is an antibacterial medicine used to treat adult patients with complicated skin and skin structure infections 1
- Daptomycin can be used to treat patients with MRSA or “superbug” infections2
- Introduction of Daptomycin further enhances Sandoz industry-leading antibiotic portfolio, which covers 50 percent of antibiotics available worldwide
Princeton, New Jersey, July 13, 2020 — Sandoz Inc. today announced the US market introduction of Daptomycin for …